HLA
1
2
3
4
5
6
7
8
9
21 home

HLA8


CODE
PROBE
ACC.N
MAP
UCSC May 2004
REMARKS
16A
RP11-614O5 BES 16p13.13 chr16:10,455,533-10,648,602

16B
RP11-614O5 AQ361328 16p13.13 chr16:10,455,533-10,648,602

RP11-449C8 BES 16p13.12 chr16:14,275,081-14,463,453

RP11-44P2 BES 16p12.13 chr16:19,163,212-19,355,377

16C
RP11-467J24
16p12.3 chr16:19,290,201-19,451,651 HLA8p&6qcen
B-A
NLE
CH271-279L5 BES
chr5:75,621,759/chr16:19,285,157 HyA translocation HLA8p
CH271-276H20 BES
chr5:75,638,548/chr16:19,300,749

5H
RP11-204O23 BES
chr5:75,668,456-75,845,041 HLA8p&6qcen

RP11-944F8 BES 5q13.3 chr5:75,479,146-75,660,029

RP11-172K14 AFMA348WD1 5q13.3 chr5:74,563,429-74,563,728
5G
RP11-480H11 AC016643 5q12.3 chr5:65,059,160-65,239,118
5F
RP11-105M3 BES 5q11.2 chr5:54,132,527-54,318,331

5E RP11-160F8 AC034246 5q11.2 chr5:53,365,247-53,520,260

5D RP11-317O24 BES
chr5:50,100,508-50,293,531

CENTROMERE




B-L





HLA fusion
22A
CTA-115F6 BES 22q11.2 chr22:16,153,880-16,340,333

CTA-322B1 BES 22q11.23 chr22:22,639,817-22,716,609
22B CTA-57G9 BES 22q12.1 chr22:27,837,088-27,950,960
B-N NLE CH271-340F4 BES
chr22:31,155,960/chr4:140.754.577 HLA8q&2q
22C
CTA-415G2 BES 22q12.3 chr22:31,690,491-31,820,448

CTA-250D10 BES 22q13.2 chr22:40,577,264-40,798,159
22D
RP5-925J7 AL078622 22q13.32 chr22:47,675,206-47,773,652
B-L





HLA fusion
17A
RP11-411G7 AC027455 17p13.3 chr17:427,025-572,435

RP11-655D3 AC026591 17p13.1 chr17:9,660,550-9,814,021
17B
RP11-746E8 BES 17p12 chr17:12,435,731-12,620,614

RP11-803H14 BES 17p11.2 chr17:16,396,847-16,555,073
17C RP11-92B11
17p11.2 chr17:16,467,786-16,646,713 HLA8q&16p
B-A





HyA inversion
17N
RP11-346K10 BES 17q24.1 chr17:61,533,516-61,702,132 HLA8q&16p
B-N NLE CH271-32K04 BES chr17:59,288,449/chr2:27,705,953 HLA8q&10p
17M RP11-630H24
17q23.3 chr17:59,198,386-59,358,882

RP11-1122L1 BES 17q23.3 chr17:58,102,921-58,244,753
17L
RP11-464D20 AC008026 17q23.3 chr17:57,765,672-57,984,805
B-A





HyA translocation

9G RP11-671K21 BES 9p13.2 chr9:38,241,473-38,423,166 HLA8q&13q
B-A NLE CH271-169O22 BES
chr9:38,763,347/chr9:27,065,324 HyA inversion HLA8q
CH271-163A2 BES
chr9:38,746,375/chr9:27,098,102
9E
RP11-1006E22 BES 9p21.2 chr9:27,142,243-27,331,367 HLA8q&13p

RP11-784B21 BES 9p21.3 chr9:24,745,524-24,913,097
9D
RP11-296K11 BES 9p21.3 chr9:22,245,370-22,411,015
B-N NLE CH271-131G15 BES
chr9:22,241,811/chr9:111,392,119 HLA8q&13q

RP11-101L23 BES 9p22.1 chr9:19,132,752-19,329,389
9C
RP11-58K1 BES 9p22.3 chr9:15,874,140-16,051,195
9B RP11-472F14 AL353718 9p24.1 chr9:6,454,979-6,601,726

RP11-443B9 AL591644 9p24.3 chr9:1,901,824-1,999,570
9A RP11-143M15 BES 9p24.3 chr9:812,146-991,152
B-H HSA inversion
9H RP11-203L2 BES 9q21.1 chr9:68,528,294-68,682,365

RP11-69B23 BES 9q21.1 chr9:68,609,860-68,767,622
9I
RP11-876N18
9q13 chr9:68,871,474-69,076,493 HLA8q&13q
B-A





HyA inversion

Legend. HLA ideogram (left) showing the synteny block correspondence with the human chromosome(s) (right). Internal red numbers indicate the human corresponding chromosome. Blue and red arrows indicate concordant (blue) and inverse (red) sequence polarity (orientation) with respect to humans. Black numbers (chromosome) followed by a letter (BAC), on the right, indicate specific BACs as reported in the Supplemental Table S1.

B-H Breaks in lineages leading to HSA
B-L Breaks in lineages leading to Lar
HyA: Hylobatidae ancestor
B-A Breaks in hylobatidae ancestor
B-N Breaks in lineages leading to Nomascus
Splitting clones

home